These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Dube PH; Handley SA; Lewis J; Miller VL Infect Immun; 2004 Jun; 72(6):3561-70. PubMed ID: 15155665 [TBL] [Abstract][Full Text] [Related]
9. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. Sing A; Tvardovskaia N; Rost D; Kirschning CJ; Wagner H; Heesemann J Int J Med Microbiol; 2003 Nov; 293(5):341-8. PubMed ID: 14695062 [TBL] [Abstract][Full Text] [Related]
10. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Zhang Y; Bliska JB Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414 [TBL] [Abstract][Full Text] [Related]
11. Nucleotide-binding oligomerization domain 2 (Nod2) is dispensable for the innate immune responses of macrophages against Yersinia enterocolitica. Jeong YJ; Kim CH; Song EJ; Kang MJ; Kim JC; Oh SM; Lee KB; Park JH J Microbiol; 2012 Jun; 50(3):489-95. PubMed ID: 22752913 [TBL] [Abstract][Full Text] [Related]
12. Mononuclear phagocytes contribute to intestinal invasion and dissemination of Yersinia enterocolitica. Drechsler-Hake D; Alamir H; Hahn J; Günter M; Wagner S; Schütz M; Bohn E; Schenke-Layland K; Pisano F; Dersch P; Autenrieth IB; Autenrieth SE Int J Med Microbiol; 2016 Sep; 306(6):357-66. PubMed ID: 27107739 [TBL] [Abstract][Full Text] [Related]
13. Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain. Dave MN; Silva JE; Eliçabe RJ; Jeréz MB; Filippa VP; Gorlino CV; Autenrieth S; Autenrieth IB; Di Genaro MS Infect Immun; 2016 Nov; 84(11):3172-3181. PubMed ID: 27550935 [TBL] [Abstract][Full Text] [Related]
14. Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Handley SA; Dube PH; Revell PA; Miller VL Infect Immun; 2004 Mar; 72(3):1645-56. PubMed ID: 14977972 [TBL] [Abstract][Full Text] [Related]
15. Unique virulence properties of Yersinia enterocolitica O:3--an emerging zoonotic pathogen using pigs as preferred reservoir host. Valentin-Weigand P; Heesemann J; Dersch P Int J Med Microbiol; 2014 Oct; 304(7):824-34. PubMed ID: 25172222 [TBL] [Abstract][Full Text] [Related]
16. Invasiveness of Yersinia enterocolitica lacking the virulence plasmid: an in-vivo study. Lian CJ; Hwang WS; Kelly JK; Pai CH J Med Microbiol; 1987 Nov; 24(3):219-26. PubMed ID: 3669055 [TBL] [Abstract][Full Text] [Related]
17. Yersinia-triggered arthritis in IL-12p40-deficient mice: relevant antigens and local expression of Toll-like receptor mRNA. Di Genaro MS; Cargnelutti DE; Castro DO; Eliçabe RJ; Gutiérrez JV; Correa SG; de Guzmán AM Scand J Rheumatol; 2007; 36(1):28-35. PubMed ID: 17454932 [TBL] [Abstract][Full Text] [Related]
18. In vivo tracking and protective properties of Yersinia-specific intestinal T cells. Kempf VA; Bohn E; Noll A; Bielfeldt C; Autenrieth IB Clin Exp Immunol; 1998 Sep; 113(3):429-37. PubMed ID: 9737673 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel porin involved in systemic Yersinia enterocolitica infection. Mildiner-Earley S; Miller VL Infect Immun; 2006 Jul; 74(7):4361-5. PubMed ID: 16790812 [TBL] [Abstract][Full Text] [Related]